ENZYME-IMMUNOASSAY FOR FLECAINIDE

被引:2
作者
FRECHE, JP
COUDERT, G
WELLMAN, M
SIEST, G
机构
[1] CTR MEDICAMENT,CNRS,URA 597,30 RUE LIONNOIS,F-54000 NANCY,FRANCE
[2] SOC STABILIGEN,CTR VIE PARC ACT NANCY BRABOIS,VANDOEUVRE NANCY,FRANCE
关键词
Enzyme immunoassay; Flecainide; Flecainide-hemifumarate-horseradish peroxidase; Flecainide-hemisuccinate-bovine serum albumin;
D O I
10.1016/0009-8981(90)90167-Q
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In order to develop an enzyme immunoassay (ELISA) for measurement of plasma flecainide levels, we first synthesized flecainide-hemisuccinate-BSA as immunogen. A highly specific antiserum was then raised in rabbits. Enzyme-labelled flecainide was prepared by the mixed anhydride method using hemifumarate-flecainide and horse radish peroxidase. The limit of detection was 10 ng/ml, the method was linear up to 1000 μg/l. The intra and inter-assay variation was 5.1-7.8%. Cross reactivity with various metabolites of flecainide or some chemically related drugs was < 0.1%. By contrast the cross reaction with some structural analogues achieved 25%. The importance of parts of the aromatic ring structure in immunogenic properties of this drug is discussed. © 1990.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 12 条
  • [1] ORAL FLECAINIDE ACETATE FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS
    ANDERSON, JL
    STEWART, JR
    PERRY, BA
    VANHAMERSVELD, DD
    JOHNSON, TA
    CONARD, GJ
    CHANG, SF
    KVAM, DC
    PITT, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (09) : 473 - 477
  • [2] CHANG SF, 1983, ARZNEIMITTEL-FORSCH, V33-1, P251
  • [3] APPLICATION OF A BONDED-PHASE EXTRACTION COLUMN FOR RAPID SAMPLE PREPARATION OF FLECAINIDE FROM HUMAN-PLASMA FOR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS - FLUORESCENCE OR ULTRAVIOLET DETECTION
    CHANG, SF
    MILLER, AM
    FOX, JM
    WELSCHER, TM
    [J]. THERAPEUTIC DRUG MONITORING, 1984, 6 (01) : 105 - 111
  • [4] DEVELOPMENT OF FLUOROIMMUNOASSAYS FOR FLECAINIDE
    COXON, RE
    HODGKINSON, AJ
    SIDKI, AM
    LANDON, J
    GALLACHER, G
    [J]. THERAPEUTIC DRUG MONITORING, 1987, 9 (04) : 478 - 483
  • [5] FLUOROMETRIC LIQUID-CHROMATOGRAPHIC ASSAY OF THE ANTIARRHYTHMIC AGENT FLECAINIDE IN BLOOD-PLASMA
    DEJONG, JW
    HEGGE, JAJ
    HARMSEN, E
    DETOMBE, PP
    [J]. JOURNAL OF CHROMATOGRAPHY, 1982, 229 (02): : 498 - 502
  • [6] SUPPRESSION OF RESISTANT VENTRICULAR ARRHYTHMIAS BY TWICE DAILY DOSING WITH FLECAINIDE
    DUFF, HJ
    RODEN, DM
    MAFFUCCI, RJ
    VESPER, BS
    CONARD, GJ
    HIGGINS, SB
    OATES, JA
    SMITH, RF
    WOOSLEY, RL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (06) : 1133 - 1140
  • [7] DIRECT CONVERSION OF CARBOXYLIC-ACIDS INTO AMIDES
    GRIECO, PA
    CLARK, DS
    WITHERS, GP
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1979, 44 (16) : 2945 - 2947
  • [8] HOSODA H, 1986, CHEM PHARM BULL, V34, P2105
  • [9] QUANTITATION OF FLECAINIDE ACETATE, A NEW ANTIARRHYTHMIC AGENT, IN BIOLOGICAL-FLUIDS BY GAS-CHROMATOGRAPHY WITH ELECTRON-CAPTURE DETECTION
    JOHNSON, JD
    CARLSON, GL
    FOX, JM
    MILLER, AM
    CHANG, SF
    CONARD, GJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (10) : 1469 - 1471
  • [10] THE INFLUENCE OF THE SPARTEINE DEBRISOQUIN PHENOTYPE ON THE DISPOSITION OF FLECAINIDE
    MIKUS, G
    GROSS, AS
    BECKMANN, J
    HERTRAMPF, R
    GUNDERTREMY, U
    EICHELBAUM, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) : 562 - 567